{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T21:16:57Z","timestamp":1774905417061,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mortality of acute-on-chronic liver failure (ACLF) patients complicated with invasive pulmonary aspergillosis (IPA) was extremely high. We aimed to explore prognostic value of the Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) lung score and to establish an optimal voriconazole regimen for ACLF patients complicated with IPA. We retrospectively screened hospitalized ACLF patients in our hospital from July 2011 to April 2016, from which 20 probable IPA cases were diagnosed. Along with onsets of IPA, deteriorated diseases severity, especially lung conditions were found in those 20 ACLF patients. It was found that IPA patients with CLIF-SOFA lung score &lt;2 had better 28-day survival than those with lung score &gt;1 (11\/13 vs 0\/7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Based on plasma voriconazole concentration measurement, an optimal voriconazole regimen (loading doses: 0.2\u2009g twice daily; maintenance doses, 0.1\u2009g once daily) was established, which resulted in rational trough plasma drug concentrations (1\u20135\u2009\u03bcg\/mL), good clinical outcomes (90-day survival rate of 6\/8) and no observed adverse events. In conclusion, CLIF-SOFA lung score &gt;1 was able to identify ACLF patients complicated with IPA encountering much higher 28-day mortality. An optimal voriconazole regimen was safe and effective in our ACLF patients complicated with IPA.<\/jats:p>","DOI":"10.1038\/s41598-018-19320-2","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T10:10:26Z","timestamp":1515665426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuankui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongpeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"19320_CR1","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau, R. et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 144, 1426\u20131437 (2013).","journal-title":"Gastroenterology."},{"key":"19320_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep25487","volume":"6","author":"H Li","year":"2016","unstructured":"Li, H. et al. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B. Sci Rep. 6, 25487 (2016).","journal-title":"Sci Rep."},{"key":"19320_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.27795","volume":"62","author":"Y Shi","year":"2015","unstructured":"Shi, Y. et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology. 62, 232\u2013242 (2015).","journal-title":"Hepatology."},{"key":"19320_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/MCG.0b013e3181d7b354","volume":"44","author":"AL Bienvenu","year":"2010","unstructured":"Bienvenu, A. L. et al. Acute liver failure may lead to lethal pulmonary aspergillosis. J Clin Gastroenterol. 44, 593\u2013594 (2010).","journal-title":"J Clin Gastroenterol."},{"key":"19320_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/13693786.2010.535030","volume":"49","author":"M Falcone","year":"2011","unstructured":"Falcone, M., Massetti, A. P., Russo, A., Vullo, V. & Venditti, M. Invasive aspergillosis in patients with liver disease. Med Mycol. 49, 406\u2013413 (2011).","journal-title":"Med Mycol."},{"key":"19320_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","volume":"60","author":"T Gustot","year":"2014","unstructured":"Gustot, T. et al. Invasive aspergillosis in patients with severe alcoholic hepatitis. J Hepatol. 60, 267\u2013274 (2014).","journal-title":"J Hepatol."},{"key":"19320_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/QCO.0000000000000043","volume":"27","author":"D Koulenti","year":"2014","unstructured":"Koulenti, D., Garnacho, M. J. & Blot, S. Approach to invasive pulmonary aspergillosis in critically ill patients. Curr Opin Infect Dis. 27, 174\u2013183 (2014).","journal-title":"Curr Opin Infect Dis."},{"key":"19320_CR8","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMra0808853","volume":"360","author":"BH Segal","year":"2009","unstructured":"Segal, B. H. Aspergillosis. N Engl J Med. 360, 1870\u20131884 (2009).","journal-title":"N Engl J Med."},{"key":"19320_CR9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.7150\/ijms.6824","volume":"10","author":"J Chen","year":"2013","unstructured":"Chen, J., Yang, Q., Huang, J. & Li, L. Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study. Int J Med Sci. 10, 1625\u20131631 (2013).","journal-title":"Int J Med Sci."},{"key":"19320_CR10","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1177\/030006051204000537","volume":"40","author":"Z Wu","year":"2012","unstructured":"Wu, Z., Ling, Z., Shao, F., Sheng, J. & Li, L. Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure. J Int Med Res. 40, 1958\u20131965 (2012).","journal-title":"J Int Med Res."},{"key":"19320_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10096-010-1137-2","volume":"30","author":"W Wang","year":"2011","unstructured":"Wang, W. et al. Invasive pulmonary aspergillosis in patients with HBV-related liver failure. Eur J Clin Microbiol Infect Dis. 30, 661\u2013667 (2011).","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"19320_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/cid\/ciw444","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson, T. F. et al. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 63, 433\u2013442 (2016).","journal-title":"Clin Infect Dis."},{"key":"19320_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijantimicag.2014.05.019","volume":"44","author":"MJ Dolton","year":"2014","unstructured":"Dolton, M. J. & McLachlan, A. J. Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity. Int J Antimicrob Agents. 44, 183\u2013193 (2014).","journal-title":"Int J Antimicrob Agents."},{"key":"19320_CR14","unstructured":"Pfizer Inc. Vfend (voriconazole) package insert. New York, NY (2011)."},{"issue":"5","key":"19320_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","volume":"61","author":"R Jalan","year":"2014","unstructured":"Jalan, R. et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. Journal of Hepatology. 61(5), 1038 (2014).","journal-title":"Journal of Hepatology."},{"issue":"1","key":"19320_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0885066610383949","volume":"26","author":"G Richards","year":"2011","unstructured":"Richards, G. et al. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS. J Intensive Care Med. 26(1), 34\u201340 (2011).","journal-title":"J Intensive Care Med."},{"key":"19320_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","volume":"186","author":"SI Blot","year":"2012","unstructured":"Blot, S. I. et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 186, 56\u201364 (2012).","journal-title":"Am J Respir Crit Care Med."},{"issue":"12","key":"19320_CR18","first-page":"1786","volume":"57","author":"M Ma\u0142gorzata","year":"2013","unstructured":"Ma\u0142gorzata, M. et al. Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis[J]. Clinical Infectious Diseases. 57(12), 1786\u20131787 (2013).","journal-title":"Clinical Infectious Diseases."},{"key":"19320_CR19","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/AAC.00626-12","volume":"56","author":"MJ Dolton","year":"2012","unstructured":"Dolton, M. J. et al. Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. Antimicrob Agents Chemother. 56, 4793\u20134799 (2012).","journal-title":"Antimicrob Agents Chemother."},{"key":"19320_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/17425255.2011.627854","volume":"7","author":"PO Gubbins","year":"2011","unstructured":"Gubbins, P. O. Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450. Expert Opin Drug Metab Toxicol. 7, 1411\u20131429 (2011).","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"19320_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1345\/aph.1K530","volume":"42","author":"EM Yakiwchuk","year":"2008","unstructured":"Yakiwchuk, E. M., Foisy, M. M. & Hughes, C. A. Complexity of interactions between voriconazole and antiretroviral agents. Ann Pharmacother. 42, 698\u2013703 (2008).","journal-title":"Ann Pharmacother."},{"key":"19320_CR22","first-page":"232","volume":"98","author":"M Chayakulkeeree","year":"2015","unstructured":"Chayakulkeeree, M., Poovipirom, N., Siengwattana, P. & Maneerattanaporn, M. Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients. J Med Assoc Thai. 98, 232\u2013237 (2015).","journal-title":"J Med Assoc Thai."},{"key":"19320_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin, S. K. et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 3, 269\u2013282 (2009).","journal-title":"Hepatol Int."},{"key":"19320_CR24","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1128\/JCM.03500-13","volume":"52","author":"LJ Wheat","year":"2014","unstructured":"Wheat, L. J. et al. Long-term stability at \u221220 degrees C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens. J Clin Microbiol. 52, 2108\u20132111 (2014).","journal-title":"J Clin Microbiol."},{"key":"19320_CR25","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"PB De","year":"2008","unstructured":"De, P. B. et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 46, 1813\u20131821 (2008).","journal-title":"Clin Infect Dis."},{"key":"19320_CR26","doi-asserted-by":"publisher","unstructured":"Fern\u00e3, J. et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 314240, https:\/\/doi.org\/10.1136\/gutjnl-2017-314240 (2017).","DOI":"10.1136\/gutjnl-2017-314240"},{"key":"19320_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijantimicag.2014.08.012","volume":"45","author":"II Raad","year":"2015","unstructured":"Raad, I. I. et al. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 45, 283\u2013288 (2015).","journal-title":"Int J Antimicrob Agents."},{"issue":"1","key":"19320_CR28","first-page":"48","volume":"18","author":"H Zhao","year":"2012","unstructured":"Zhao, H. et al. The clinical characteristics of aspergillosis in patients with liver failure. The journal of Hai Nan Medical University. 18(1), 48\u201351 (2012).","journal-title":"The journal of Hai Nan Medical University."},{"issue":"4","key":"19320_CR29","first-page":"705","volume":"22","author":"Y Zhou","year":"2012","unstructured":"Zhou, Y., Qian, Z. P., Zhang, Y. Y., Wang, J. F. & Wang, J. W. The clinical characteristics and treatment of aspergillosis in patients with liver failure. The infection journal of Chinese Medical Hospital. 22(4), 705\u20138 (2012).","journal-title":"The infection journal of Chinese Medical Hospital."},{"key":"19320_CR30","unstructured":"Liu, J. Y., Xu, Y. L., Wei, L. R., Wang, H. Z. & Song, L. H. The risk factor and pulmonary radiologic characteristics of IPA in patients with liver failure. The journal of Chinese experiment and clinical infection disease. electric version (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19320-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19320-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:58:52Z","timestamp":1671584332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19320-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19320"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19320-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"8 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"876"}}